These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 34091456)

  • 1. Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID.
    Funke-Chambour M; Bridevaux PO; Clarenbach CF; Soccal PM; Nicod LP; von Garnier C;
    Respiration; 2021; 100(8):826-841. PubMed ID: 34091456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Return-to-work, disabilities and occupational health in the age of COVID-19.
    Godeau D; Petit A; Richard I; Roquelaure Y; Descatha A
    Scand J Work Environ Health; 2021 Jul; 47(5):408-409. PubMed ID: 34003294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).
    Bai C; Chotirmall SH; Rello J; Alba GA; Ginns LC; Krishnan JA; Rogers R; Bendstrup E; Burgel PR; Chalmers JD; Chua A; Crothers KA; Duggal A; Kim YW; Laffey JG; Luna CM; Niederman MS; Raghu G; Ramirez JA; Riera J; Roca O; Tamae-Kakazu M; Torres A; Watkins RR; Barrecheguren M; Belliato M; Chami HA; Chen R; Cortes-Puentes GA; Delacruz C; Hayes MM; Heunks LMA; Holets SR; Hough CL; Jagpal S; Jeon K; Johkoh T; Lee MM; Liebler J; McElvaney GN; Moskowitz A; Oeckler RA; Ojanguren I; O'Regan A; Pletz MW; Rhee CK; Schultz MJ; Storti E; Strange C; Thomson CC; Torriani FJ; Wang X; Wuyts W; Xu T; Yang D; Zhang Z; Wilson KC
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33020069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary function and chest computed tomography abnormalities 6-12 months after recovery from COVID-19: a systematic review and meta-analysis.
    Lee JH; Yim JJ; Park J
    Respir Res; 2022 Sep; 23(1):233. PubMed ID: 36068582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pulmonary manifestations in long COVID].
    Sommer N; Schmeck B
    Inn Med (Heidelb); 2022 Aug; 63(8):819-829. PubMed ID: 35925073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.
    Bellan M; Soddu D; Balbo PE; Baricich A; Zeppegno P; Avanzi GC; Baldon G; Bartolomei G; Battaglia M; Battistini S; Binda V; Borg M; Cantaluppi V; Castello LM; Clivati E; Cisari C; Costanzo M; Croce A; Cuneo D; De Benedittis C; De Vecchi S; Feggi A; Gai M; Gambaro E; Gattoni E; Gramaglia C; Grisafi L; Guerriero C; Hayden E; Jona A; Invernizzi M; Lorenzini L; Loreti L; Martelli M; Marzullo P; Matino E; Panero A; Parachini E; Patrucco F; Patti G; Pirovano A; Prosperini P; Quaglino R; Rigamonti C; Sainaghi PP; Vecchi C; Zecca E; Pirisi M
    JAMA Netw Open; 2021 Jan; 4(1):e2036142. PubMed ID: 33502487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study.
    Nurek M; Rayner C; Freyer A; Taylor S; Järte L; MacDermott N; Delaney BC;
    Br J Gen Pract; 2021 Nov; 71(712):e815-e825. PubMed ID: 34607799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [S1 Guideline Post-COVID/Long-COVID].
    Koczulla AR; Ankermann T; Behrends U; Berlit P; Böing S; Brinkmann F; Franke C; Glöckl R; Gogoll C; Hummel T; Kronsbein J; Maibaum T; Peters EMJ; Pfeifer M; Platz T; Pletz M; Pongratz G; Powitz F; Rabe KF; Scheibenbogen C; Stallmach A; Stegbauer M; Wagner HO; Waller C; Wirtz H; Zeiher A; Zwick RH
    Pneumologie; 2021 Nov; 75(11):869-900. PubMed ID: 34474488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ESCMID rapid guidelines for assessment and management of long COVID.
    Yelin D; Moschopoulos CD; Margalit I; Gkrania-Klotsas E; Landi F; Stahl JP; Yahav D
    Clin Microbiol Infect; 2022 Jul; 28(7):955-972. PubMed ID: 35182760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Sequelae at 4 Months After COVID-19 Infection: A Single-Centre Experience of a COVID Follow-Up Service.
    Robey RC; Kemp K; Hayton P; Mudawi D; Wang R; Greaves M; Yioe V; Rivera-Ortega P; Avram C; Chaudhuri N
    Adv Ther; 2021 Aug; 38(8):4505-4519. PubMed ID: 34278556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Function and Long-Term Respiratory Symptoms in Children and Adolescents After COVID-19.
    Knoke L; Schlegtendal A; Maier C; Eitner L; Lücke T; Brinkmann F
    Front Pediatr; 2022; 10():851008. PubMed ID: 35547532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.